Hybrisan is a MedTech product development company who have developed the WoundSan platform, a wound irrigation solution that disrupts biofilms that form over chronic wounds in order to improve healing and prevent infection.
SymlConnect is a Swansea-based digital health company who develop software for patient-clinician communication. Software developed by the company include solutions for primary care including remote patient engagement and communication, offline consultations at the point of care and SMART digital surveys.
Springdew is a Swansea-based packaging company, serving primarily pharmaceutical, healthcare, veterinary and medical device markets. Springdew holds an MHRA licence for the secondary packaging & assembly of human and veterinary medicines.
ProColl is a synthetic biology company that manufactures bovine and animal-free collagen at scale. This collagen is used in industries such as medical devices, cell therapy and regenerative medicine, as well as in food production.
Osteo Plus is a medical device company based in Swansea. Osteo Plus is focused on manufacturing and supplying anatomical surgical models to aid surgeons in pre-operative planning, as well as developing custom implants for orthopaedic oncology and orthopaedic veterinary surgery. Osteo also manufactures custom surgical instruments.
My Mask Fit is a Swansea based medical device company which are developing custom-fit P3 standard transparent facemasks made by scanning a customer's face with a mobile application.
Medical Connections is a Swansea-based software and consultancy business, which offers software toolkits to the developers of medical imaging technologies.
Kaydiar is a medical device company that is developing ZeroSole, a modular, silicone insole that is designed to reduce pressure on foot wounds and lesions.
Haemair is a developer of medical devices centred around blood and lung care. Products developed by Haemair include an extracorporeal Life Support system, a compact blood oxygenator, a low haemolysis pulsatile blood pump and a device for treating the comorbidities of Acute Respiratory Distress Syndrome and Acute Kidney Injury.
Haemaflow develop products to support people with lung disease or damage. The company is 100% owned by Haemair Ltd, but trades independently. Haemaflow’s products include a pulsatile blood pump, devices to improve blood transfusion, a point-of-care rheometer to assess the propensity of blood to clot and a non-contact analyser to determine the concentration of species within gas mixtures or dissolved in liquids without taking a sample.
